Wright Medical Group (WMGI) Announces FDA Approval For CONSERVE Plus Total Hip Resurfacing System
More News related to WMGI
- Wright Medical Group, Inc. Announces Initial Release of the VALOR(TM) Ankle Fusion Nail System
- Wright Medical Group, Inc. to Participate in Piper Jaffray's 21st Annual Healthcare Conference
- Wright Medical Group (WMGI) Appoints Lance A. Berry as CFO
- Wright Medical Group, Inc. Announces Chief Financial Officer Transition
- Wright Medical Group (WMGI) Announces FDA Approval For CONSERVE Plus Total Hip Resurfacing System
More News related to FDA
- Cornerstone Therapeutics (CRTX) Receives Warning Letter From FDA
- Pfizer (PFE) Gets Okay for Bipolar Treatment Geodon from U.S. FDA
- Intuitive Surgical (ISRG) Receives Japanese Approval for da Vinci
- Dendreon Corp. (DNDN) Receives U.S. FDA Complete Response for PROVENGE CRPC Treatment
- Boston Scientific (BSX) Receives 510(k) Clearance and CE Mark on WallFlex
Wright Medical Group, Inc. (NASDAQ: WMGI) said the FDA has given approval to the Company to market its original CONSERVE® Plus Total Hip Resurfacing System. Now available in the United States, this innovative total surface arthroplasty system provides surgeons and their patients a bone-conserving alternative to traditional total hip replacement.
Related Categories
FDAStocks Mentioned
+0.39Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
